Similar articles

• Tumor-specific cellular immunity.

  Cohen AM, Burdick JF, Ketcham AS. Cohen AM, et al. J Surg Res. 1971 Aug;11(8):421-31. doi: 10.1016/0022-4804(71)90150-8. J Surg Res. 1971. PMID: 4936302 Review. No abstract available.
• Levels of Ia-like antigen bearing lymphocytes in patients with solid primary tumors.

  Cordiali-Fei P, Natali PG, Pecci G, Pellegrino MA, Ferrone S. Cordiali-Fei P, et al. J Clin Lab Immunol. 1981 Nov;6(3):197-9. J Clin Lab Immunol. 1981. PMID: 6951050
• Antigen-reactive cells to tumor antigens in normal and tumor patients.

  Falk RE, MacGregor AB. Falk RE, et al. J Surg Res. 1976 Mar;20(3):247-53. doi: 10.1016/0022-4804(76)90148-7. J Surg Res. 1976. PMID: 772313 No abstract available.
• A comparison of the macrophage electrophoretic mobility test and the leukocyte migration inhibition test in the detection of histocompatibility antigens on tumor cells.

  Bubeník J, Cochran AJ, Todd G, Malkovský M, Jandlová T, Suhajová E, Boubelík M. Bubeník J, et al. Neoplasma. 1981;28(2):185-93. Neoplasma. 1981. PMID: 7019742
• [Immunological exploration of cancer patients. II. Tumoral immunity].

  Cappelaere P, Demaille A, Adenis L. Cappelaere P, et al. Lille Med. 1973 Feb;18(2):179-201. Lille Med. 1973. PMID: 4581842 Review. French. No abstract available.